Back
Open Access

Biomarkers in action: The role of Procalcitonin, NT-proBNP, and Troponin T in predicting septic cardiomyopathy

Session: Markers in and of dilated cardiomyopathy
Topic: Dilated Cardiomyopathy
Speaker: Mr D. Ferreira (Lisbon, PT)
Event: Heart Failure 2025

Congress Presentation

Add to my library

Like

About the speaker

Mr Diogo Ferreira

Santa Maria Hospital - CHULN, Lisbon (Portugal)
0 follower

5 more presentations in this session

Influence of non-sex specific risk factors on the development of a dilated cardiomyopathy in men and women with a titin truncating variant

Speaker: Ms I. Faassen (Maastricht, NL)

Access
Abstract
Like
Thumbnail

Phenotypic manifestation based on genetics and prevalence of secondary mutations in a sample of patients diagnosed with arrhythmogenic cardiomyopathy

Speaker: Doctor A. Diaz Exposito (Malaga, ES)

Access
Abstract
Like
Thumbnail

Genetic determinants of disease severity in idiopathic dilated cardiomyopathy

Speaker: Associate Professor J. Lee (Cheongju, KR)

Access
Abstract
Like
Thumbnail

Relationship between TTN gene mutation and changes in whole-heart myocardial mechanics in patients with non-ischemic dilated cardiomyopathy: feature-tracking CMR study

Speaker: Ms G. Jakuskaite (Kaunas, LT)

Access
Abstract
Like
Thumbnail

Is left ventricular ejection fraction an effective predictor of ventricular arrhythmias in patients with dilated cardiomyopathy?

Speaker: Doctor M. Rodrigues Simoes (Coimbra, PT)

Access
Abstract
Like
Thumbnail

Access the full session

Markers in and of dilated cardiomyopathy

Speakers: Mr D. Ferreira, Ms I. Faassen, Doctor A. Diaz Exposito, Associate Professor J. Lee, Ms G. Jakuskaite...
Access
Like
Thumbnail

About the event

Image

Heart Failure 2025

17 May - 20 May 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novartis Explore sponsored resources
logo Novo Nordisk Explore sponsored resources